Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | PDE7A | Q13946 | 4/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19431337 | 0.84 | ALDH1A1 (0.47) | CYP3A4TSHRALDH1A1ALOX15SMN1; SMN2 | |
| SCHEMBL7453199 | 0.76 | CYP3A4 (0.56) | CYP3A4TSHRALDH1A1ALOX15SMN1; SMN2 | |
| SCHEMBL13840027 | 0.76 | NPC1 (0.53) | CYP3A4TSHRALDH1A1ALOX15SMN1; SMN2 | |
| SCHEMBL11298759 | 0.73 | CYP3A4 (0.48) | CYP3A4TSHRALDH1A1ALOX15SMN1; SMN2 | |
| SCHEMBL30422063 | 0.72 | CYP3A4 (0.52) | CYP3A4TSHRALDH1A1ALOX15SMN1; SMN2 | |
| SCHEMBL3783594 | 0.72 | CYP3A4 (0.52) | CYP3A4TSHRALDH1A1ALOX15SMN1; SMN2 | |
| SCHEMBL6510514 | 0.71 | CYP3A4 (0.41) | CYP3A4TSHRALDH1A1ALOX15SMN1; SMN2 | |
| SCHEMBL8263320 | 0.70 | MEN1 (0.56) | CYP3A4TSHRALDH1A1ALOX15SMN1; SMN2 | |
| SCHEMBL3789429 | 0.69 | CYP3A4 (0.48) | CYP3A4TSHRALDH1A1ALOX15SMN1; SMN2 | |
| SCHEMBL4962252 | 0.69 | MEN1 (0.53) | CYP3A4TSHRALDH1A1ALOX15SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10407619-B2 | Liquid crystal composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-09-10 | — | — | US | disclosed |
| US-20170335191-A1 | LIQUID CRYSTAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170335191-A1 | LIQUID CRYSTAL COMPOSITION | RCC1, CCDC47, ACIN1 | CYP3A4 3978/4885TSHR 4627/4885ALDH1A1 4362/4885 |
| US-10407619-B2 | Liquid crystal composition | RCC1, CCDC47, ACIN1 | CYP3A4 3978/4885TSHR 4627/4885ALDH1A1 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.